Continuing education. Considerations in pharmacy compounding and the treatment of spasticity.
- Published in:
- 2009
- Publication type:
- Journal Article
Works matching IS 10792082 AND DT 2009 AND VI 66 AND IP S5
Results: 5
1
2
Pharmacy compounding of high-risk level products and patient safety.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. S5, p. S4, doi. 10.2146/ajhp0108b
- By:
- Publication type:
- Article
3
Considerations in pharmacy compounding and the treatment of spasticity.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. S5, p. S23
- Publication type:
- Article
4
Considerations in pharmacy compounding and the treatment of spasticity.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. S5, p. S2, doi. 10.2146/ajhp0108a
- By:
- Publication type:
- Article
5
Considerations in the treatment of spasticity with intrathecal baclofen.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. S5, p. S14, doi. 10.2146/ajhp0108c
- By:
- Publication type:
- Article